|
General Information
|
|
|
Product
|
KLF6 SV1 Peptide
|
|
Description
|
Antigenic Blocking Peptide Kruppel-like factor 6 SV1
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 170-220 on human KLF6 protein.
|
|
Accession #
|
GenBank: EAW86478.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
| Overview |
Transcriptional activator (By similarity). Binds a GC box motif. Could play a role in B-cell growth and development. |
| Molecular Function |
DNA binding; Metal ion binding |
| Subcellular Location |
Nucleus |
| Expression |
Highly expressed in placenta followed by spleen, thymus, prostate, testis, small intestine and colon. Weakly expressed in pancreas, lung, liver, heart and skeletal muscle. Also expressed in fetal brain, spleen and thymus. |
| Structure |
The acidic N-terminal part may favor interaction with the basic domain of transcription factors. |
|
Alternative Nomenclature
|
B cell derived protein 1 antibody
CBA1 antibody
COPEB antibody
GBF antibody
GC rich binding factor antibody
Klf6 antibody
Kruppel like zinc finger protein Zf9 antibody
PAC1 antibody
Proto-oncogene BCD1 antibody
ST12 antibody
Transcription factor Zf9 antibody
Zf9 antibody
|
| |
|
KLF6 SV1 Antibody
KLF6 SV1 Antibody FITC
KLF6 SV1 Antibody BIOTIN
KLF6 Positive Control
